The Analytical Scientist / Issues / 2026 / June / The New Reality of Peptide Analysis
Pharma and Biopharma

The New Reality of Peptide Analysis

Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows

06/15/2026 6 min read

Share

Top Institutions in Biochemistry

Ranking combines internal corpus citation frequency with web search results due to limited internal data for this topic.

  • #1

    Johns Hopkins University School of Medicine

    Baltimore, Maryland

    Johns Hopkins is a leader in peptide analysis through its involvement in the NCI CPTAC and extensive clinical trial activity. It has a strong publication record in proteogenomics.

    Key Differentiators

    • Biochemistry
    • Proteomics

  • #2

    Mayo Clinic

    Rochester, Minnesota

    Mayo Clinic is recognized for its translational research in proteomics and has a strong focus on clinical applications of peptide analysis.

    Key Differentiators

    • Biochemistry
    • Proteomics

Recommended

Related Content

Loading the Molecular Dice
Pharma and Biopharma
Loading the Molecular Dice

December 12, 2024

2 min read

How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research

CD-MS: To Megadalton and Beyond
Pharma and Biopharma
CD-MS: To Megadalton and Beyond

October 1, 2024

10 min read

Charge-detection mass spectrometry (CD-MS) has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development and exciting new applications in complex protein mixtures, maturity beckons

New NMR Technique Enables Direct Detection of Molecular Chirality
Pharma and Biopharma
New NMR Technique Enables Direct Detection of Molecular Chirality

October 1, 2024

1 min read

Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents

Mass Spec Imaging Meets Proteomics
Pharma and Biopharma
Mass Spec Imaging Meets Proteomics

October 2, 2024

2 min read

Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment